GlaxoSmithKline Stock Forecast
GlaxoSmithKline stock price ended at $39.27 on Thursday, after losing 0.83%.
(Updated on Apr 18, 2024)
The GlaxoSmithKline stock price fell by -0.83% on the last day (Thursday, 18th Apr 2024) from $39.60 to $39.27. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 0.88% from a day low at $39.16 to a day high of $39.50. The price has fallen in 7 of the last 10 days and is down by -3.89% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -608 thousand shares and in total, 2 million shares were bought and sold for approximately $83.58 million.
Given the current short-term trend, the stock is expected to rise 2.84% during the next 3 months and, with a 90% probability hold a price between $40.38 and $45.40 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
GSK Signals & Forecast
There are few to no technical positive signals at the moment. The GlaxoSmithKline stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $40.21 and $41.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -9.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for GlaxoSmithKline stock
GlaxoSmithKline finds support from accumulated volume at $39.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.345 (0.88%) between high and low. For the last week, the stock has had daily average volatility of 1.18%.
GlaxoSmithKline is oversold on RSI14 (10). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: $36.69 (-6.58%) (This stock has low daily movements and this gives low risk. Low RSI14 is 10 which reduces the risk some. There is a sell signal from a pivot top found 29 days ago.)
Trading Expectations (GSK) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect GlaxoSmithKline PLC to open at $39.31, and during the day (based on 14 day Average True Range), to move between $38.71 and $39.83, which gives a possible trading interval of +/-$0.555 (+/-1.41%) up or down from last closing price. If GlaxoSmithKline PLC takes out the full calculated possible swing range there will be an estimated 2.83% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $39.44 (0.43%) than the support at $39.07 (0.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is GlaxoSmithKline PLC stock A Buy?
GlaxoSmithKline holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: -0.191 Hold/Accumulate Unchanged
Predicted Opening Price for GlaxoSmithKline PLC of Friday, April 19, 2024
Fair opening price April 19, 2024 | Current price |
---|---|
$39.31 ( 0.0976%) | $39.27 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for GSK
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 39.65 | 0.98 % | |
R2 | 39.52 | 0.641 % | ||
R1 | 39.44 | 0.433 % | ||
Current price: | 39.27 | |||
Support | S1 | 39.18 | -0.238 % | |
S2 | 39.10 | -0.445 % | ||
S3 | 38.96 | -0.781 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 42.02 | 7.00 % | |
R2 | 41.94 | 6.80 % | ||
R1 | 39.44 | 0.433 % | ||
Current price | 39.27 | |||
Support | S1 | 39.07 | -0.509% | |
S2 | 39.03 | -0.611% | ||
S3 | 38.84 | -1.09% |
GSK Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Feb 01, 2024 | Feb 22, 2024 | Apr 11, 2024 | $0.399 | 0.98% |
2 | Nov 01, 2023 | Nov 16, 2023 | Jan 11, 2024 | $0.340 | 0.86% |
3 | Jul 26, 2023 | Aug 17, 2023 | Oct 12, 2023 | $0.361 | 0.98% |
4 | Apr 26, 2023 | May 18, 2023 | Jul 13, 2023 | $0.348 | 1.00% |
5 | Feb 01, 2023 | Feb 23, 2023 | Jul 13, 2023 | $0.340 | 0.98% |
FAQ
Click here for our free guide on how to buy GlaxoSmithKline Stock.